Back to School: How biopharma can reboot drug development. Access exclusive analysis here

ALRN-5281: Phase I data

Data from 32 evaluable healthy adults in a single-blind, placebo-controlled,

Read the full 105 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE